Evidence map›Paper›PMID 25225244›Full record

ArticleInfection and immunity2014

Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin.

T Zangari, A R Melton-Celsa, A Panda, M A Smith, I Tatarov, L De Tolla, A D O'Brien

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Predicting clinical outcome ofMicrobial genomics · 2025
    Article
  2. Shiga toxin-producingMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  3. Article
  4. Article
  5. Nitric Oxide InducedMicroorganisms · 2022
    Article
  6. Review
  7. Article
  8. Treatment Strategies for Infections With Shiga Toxin-ProducingFrontiers in cellular and infection microbiology · 2020
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

T ZangariDepartment of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
A R Melton-CelsaDepartment of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
A PandaProgram of Comparative Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA Departments of Pathology, Epidemiology, and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
M A SmithDepartment of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
I TatarovProgram of Comparative Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
L De TollaProgram of Comparative Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA Departments of Pathology, Epidemiology, and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA Department of Medicine (Infectious Diseases), University of Maryland, School of Medicine, Baltimore, Maryland, USA.
A D O'BrienDepartment of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA alison.obrien@usuhs.edu.
Uniformed Services University of the Health Sciences · USUniversity of Maryland, Baltimore · US

Funding

Pathogenicity of Shiga Toxin Producing E.coliR37AI020148 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI O'BRIEN, ALISON DAVIS · 2008 to 2016
$3.8M
NIAID NIH HHS R37 AI020148
6 · The paper itself

Abstract

Shiga toxin (Stx)-producing Escherichia coli (STEC) causes hemorrhagic colitis and the hemolytic-uremic syndrome (HUS). STEC strains may produce Stx1a and/or Stx2a or variants of either toxin. A 2006 spinach-associated outbreak of STEC O157:H7 resulted in higher hospitalization and HUS rates than previous STEC outbreaks. The spinach isolate, strain K3995, contains both stx2a and stx2c. We hypothesized that the enhanced virulence of K3995 reflects the combination of stx2 alleles (carried on lysogenic phages) and/or the amount of Stx2 made by that strain. We compared the virulence of K3995 to those of other O157:H7 isolates and an isogenic Stx2 mutant in rabbits and mice. We also measured the relative levels of Stx2 produced from those strains with or without induction of the stx-carrying phage. Some rabbits infected with K3995 exhibited intestinal pathology and succumbed to infection, while none of those infected with O157:H7 strain 2812 (Stx1a(+) Stx2a(+)) died or showed pathological signs. Rabbits infected with the isogenic Stx2a mutant K3995 stx2a::cat were not colonized as well as those infected with K3995 and exhibited no signs of disease. In the streptomycin-treated mouse model, more animals infected with K3995 died than did those infected with O157:H7 strain 86-24 (Stx2a(+)). Additionally, K3995 produced higher levels of total Stx2 and toxin phage DNA in cultures after phage induction than did 86-24. Our results demonstrate the greater virulence of K3995 compared to other O157:H7 strains in rabbits and mice. We conclude that this enhanced virulence is linked to higher levels of Stx2 expression as a consequence of increased phage induction.

Indexed as

AnimalsAnti-Bacterial AgentsCiprofloxacinDisease Models, AnimalDisease OutbreaksEscherichia coli InfectionsEscherichia coli O157FemaleHumansIntestinesMaleMice, Inbred BALB CMice, Inbred ICRModels, AnimalRabbitsShiga Toxin 2Anti-Bacterial AgentsCiprofloxacinShiga Toxin 2

Identifiers

PMID25225244
PMCPMC4249278
OpenAlexW1999500393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.